Chongqing Runze Pharmaceutical Co., Ltd., established on 2007-12-24, Business scope includes production:Class III:6825Medical bipolar coagulator,6846-1implanted device,6846-2implantable artificial organ,6863-2Dental Implant Materials;Class II: 6810Surgical Power System,6825bipolar coagulation forceps,6863-7Metal,ceramic denture material(Engage in business according to the business scope and period approved by the respective licenses).medical instruments,Machine equipment and accessories,Chemical Products,specialty chemicals(None of the above contain hazardous chemicals),Biochemicals,Research and development of biological products and pharmaceuticals,Related technical consultation and transfer;Technical testing(Except for special regulations of the state);Sales:Class II:6810Orthopedic surgery(orthopedics)Surgical Instruments,6821Medical electronic equipment;Class II,Class III:(6846-1)Biological dural patch(6846-1)Cranial Fixation Titanium System6846Implantable materials and artificial organs(craniofacial fixation system,Cerebral Aneurysm Clips),6864Medical hygiene materials and dressings,6866Medical polymer materials and products,Chemical raw materials and their preparations,Antibiotic raw materials and their preparations,biochemical drug,Chinese patent medicine,Biological product(In addition to vaccines)(Engage in business according to the validity period and scope approved by the license);Production,Sales:environmental protection material.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Meiai KK is a Japanese private company located in Sakadoshi that operates restaurants.

Xiamen Haoboer Technology Co., Ltd., established on 2019-04-16, Business scope includes other unspecified technology promotion and application service industries;Medical Research and Experimental Development;Technology intermediary service;Biotechnology Extension Services;Business Management Consulting;Other unlisted professional consulting services(Items not subject to permit approval);Information Technology Consulting Services;software development;computer,Retailing of Software and Ancillary Equipment.

Shuguang Hospital is a private company headquartered in Shanghai, China, that operates as a hospital.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, our lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, our second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain. It was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Wenzhou Zhichuang Technology Co., Ltd., established on 2013-03-26, Business scope includes technical development of electronic products,Technical Services,technology transfer;Mechanical and electrical equipment research and development and technical consulting.

Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures. In addition to rapid product development of its initial products, Rebound has assembled a world-class Scientific Advisory Board of leading MIS physicians, filed 14 patents to solidify its intellectual property platform and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.

Jiangsu Yuruikang Biotechnology Co., Ltd., established on 2015-07-13, Business scope includes technology research and development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Technical Training;Self-operated and agent import and export business of various commodities and technologies;Research and development of biomedical technology;Biological product,R&D and sales of medical devices;Project contracting in the field of bioengineering technology,technology transfer,technical consulting,Technical Services,Technical Training;medical investment;Hospital Management Consulting Services;health management;Health Advisory;food,Healthy food,Health Equipment,Sales of simple physical therapy equipment;Self-operated and agent import and export business of various food and technology(Except for commodities and technologies that the state restricts the company to operate and prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Cosmetic production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hangzhou Nano Ablation Biotech is committed to building an innovative ablation platform based on bioelectric technology. The company has developed an internationally leading next-generation pulse ablation technology, nanosecond wave ablation, which can achieve local accurate ablation, a breakthrough into the forbidden area that traditional ablation technology can not, and is expected to create a strong immune response that can address traditional tumor surgical problems of tumor recurrence and metastasis. At present, Hangzhou Nano Ablation Biotech is about to complete the world's first registered clinical trial for nanosecond wave tumor ablation. The company has a pipeline of products targeting liver cancer, pancreatic cancer, and cardiac ablation.

Weihai Weichuang Medical Equipment Co., Ltd., established on 2015-03-25, The scope of business includes the design of medical devices,research and development,production and sales;Medical equipment,equipment design,research and development,Production,Sales and related technical consulting services;Medical protective equipment,Labor protection supplies,textile,outdoor product,clothing,Production of shoes and hats,Sales;medical lubricant,ink,Thinner,Wujinjiaodian,mold,Equipment,Instrumentation,Disinfectant(Free of Hazardous Chemicals)promotion of;Import and export of goods and technologies within the filing scope.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Well Lead Medical Co., Ltd. engages in research and development, production and sales of medical equipment in the fields of anesthesia, urology, nursing, respiratory, and hemodialysis, which are used clinically in hospital, surgery, treatment, first aid and nursing. The anesthesia products include tracheal intubation, tracheostomy intubation, bronchial intubation, laryngeal mask, anesthesia mask, artificial nose, and anesthesia breathing circuit. The urinary catheterization products include urinary catheters, catheterization bags, catheterization sets, and catheterization accessories. The nursing products include drainage, nutrition, oral care, and excrement management. The respiratory products include oxygen masks and drug inhalation nebulizers. The hemodialysis products include hemodialysis tubes. The urology products include circumcision and suture devices, guide series, expansion series, interventional channels, stone removal, ureteral stents, ureteral catheters, fistulas, and urodynamics. Its other products include nasal cavity inspection, minimally invasive, obstetrics and gynecology, and extracardiac. The company was founded on April 30, 2004 and is headquartered in Guangzhou, China.